Reforming Clinical Trials: Accelerating Drug Development and Lowering Costs
2024-12-22
A research report from the Institute for Progress (IFP) explores reform proposals for clinical trials in the US. The report highlights how lengthy and expensive clinical trials hinder medical innovation. Nine specific recommendations are proposed, including streamlining regulations, improving clinical trial databases, and adopting risk-based monitoring, aiming to accelerate new drug development and benefit more patients by increasing efficiency and reducing costs. This reflects a positive exploration of using technology (such as AI) to improve healthcare efficiency.
Read more
(ifp.org)
Tech
medical innovation